Seminal study found significantly higher risk of heart disease, stroke, breast cancer from combined hormone replacement therapy; as a result, 15,000-20,000 fewer breast cancer cases each year
Findings published by Center researchers and Women's Health Initiative colleagues support link between declining breast-cancer rates and combined hormone replacement therapy use in the United States